Drug Database
N06DA04 galantamine
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Gaalin (Galantamine) 16mg prolonged release Capsules
- POM Gaalin (Galantamine) 24mg prolonged release capsules
- POM Gaalin(Galantamine) 8mg prolonged release capules
- POM Galantamine 24 mg prolonged-release hard capsules
- POM Galantamine 4 mg/ ml Oral Solution
- POM Galantamine 4mg/ml Oral Solution
- POM Galantamine 4mg/ml Oral Solution
- POM Galantamine 8 mg prolonged-release hard capsules
- POM Galantamine16 mg prolonged-release hard capsules
- POM Galzemic 4 mg/ml Oral Solution
- POM Galzemic 4 mg/ml Oral Solution
- POM Galzemic XL 16 mg prolonged release capsules, hard
- POM Galzemic XL 16mg Prolonged Release Capsules
- POM Galzemic XL 24 mg prolonged release capsules, hard
- POM Galzemic XL 24mg Prolonged Release Capsules
- POM Galzemic XL 8 mg prolonged release capsules, hard
- POM Galzemic XL 8mg Prolonged Release Capsules
- POM Gatalin XL 16mg prolonged release capsules, hard
- POM Gatalin XL 24mg prolonged release capsules, hard
- POM Gatalin XL 8mg prolonged release capsules, hard
- POM Luventa XL 16mg prolonged release capsules, hard
- POM Luventa XL 24mg prolonged release capsules, hard
- POM Luventa XL 8mg prolonged release capsules, hard
- POM Reminyl Oral Solution
- POM Reminyl XL 8mg, 16mg and 24mg prolonged release capsules
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).